Recombinant ESAT6-MPT64 skin test Phase 1 RCT receives correction regarding safety and tolerability
Correction: Safety, tolerability, and concordance with interferon-γ release assays of a recombinant ESAT6-MPT64 skin test: a phase 1 randomized clinical trial.
Abstract
A correction was issued for a Phase 1 RCT evaluating the safety and tolerability of a recombinant ESAT6-MPT64 skin test.